alprazolam has been researched along with amitriptyline in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (30.30) | 18.7374 |
1990's | 5 (15.15) | 18.2507 |
2000's | 11 (33.33) | 29.6817 |
2010's | 7 (21.21) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bertorini, TE; Lemmi, H; Silva, AB | 1 |
Castro, P; De Maertelaer, V; Hubain, PP; Mendlewicz, J; Mesters, P | 1 |
Banerji, JR; Brantingham, P; Mason, J; McEwan, GD; Munt, DF; Renton, RL; Scott, AP; Stevens, V; Strakova, JM | 1 |
Feighner, JP; Rickels, K; Smith, WT | 1 |
Coryell, W; Moranville, JT | 1 |
Lizondo, E; Nair, NP; Schwartz, G; Singh, AN; Suranyi-Cadotte, B | 1 |
Blaschke, D; Laakmann, G; Schmauss, M | 1 |
Eriksson, B; Nagy, A; Starmark, JE; Thelander, U | 1 |
Erman, MK; Fairchild, C; Giles, DE; Khatami, M; Roffwarg, HP; Rush, AJ; Schlesser, MA; Vasavada, N | 1 |
Feighner, JP | 1 |
Daly, I; Draper, RJ | 1 |
Fairchild, C; Giles, DE; Roffwarg, HP; Rush, AJ; Schlesser, MA; Tarell, J | 1 |
Baghai, T; Bossert-Zaudig, S; Faltermaier-Temizel, M; Laakman, G; Lorkowski, G | 1 |
Bellodi, L; Bertani, A; Brambilla, F; Panerai, A; Perna, G; Sacerdote, P | 1 |
Browne, M; Lapierre, YD; Oyewumi, K; Sarantidis, D | 1 |
Christiaens, F; Dellers, I; Denis, B; Lessire, H; Vankeerberghen, L; Verborgh, C | 1 |
Möller, HJ | 1 |
Akechi, T; Akizuki, N; Ito, T; Nakano, T; Okamura, M; Shimizu, K; Uchitomi, Y | 1 |
Koval'chuk, VV | 1 |
Batt, A; Boulanger, B; Nagarnaik, P | 1 |
Curry, SC; Smith, JC | 1 |
Eren Cevik, S; Guneysel, O; Tasyurek, T | 1 |
2 review(s) available for alprazolam and amitriptyline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Anxiety associated with comorbid depression.
Topics: Adult; Algorithms; Alprazolam; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Comorbidity; Decision Trees; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Humans; Practice Patterns, Physicians'; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2002 |
12 trial(s) available for alprazolam and amitriptyline
Article | Year |
---|---|
Alprazolam and amitriptyline in the treatment of major depressive disorder: a double-blind clinical and sleep EEG study.
Topics: Adult; Alprazolam; Amitriptyline; Biomarkers; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; Electroencephalography; Female; Humans; Male; Middle Aged; Random Allocation; Sleep | 1990 |
A comparison of alprazolam with amitriptyline in the treatment of patients with neurotic or reactive depression. A report of a randomised, double blind study by a General Practitioner Working Party.
Topics: Adult; Aged; Alprazolam; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Random Allocation | 1989 |
Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression.
Topics: Adult; Alcoholism; Alprazolam; Ambulatory Care; Amitriptyline; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Doxepin; Female; Humans; Male; Outcome and Process Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Sleep Stages; Tachycardia; Vision Disorders; Xerostomia | 1985 |
A double blind comparison of alprazolam and amitriptyline hydrochloride in the treatment of nonpsychotic depression.
Topics: Adult; Alprazolam; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Psychological Tests | 1988 |
Alprazolam compared to amitriptyline in the treatment of major depression.
Topics: Adolescent; Adult; Aged; Alprazolam; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Random Allocation | 1987 |
Alprazolam vs amitriptyline in depressions with reduced REM latencies.
Topics: Adolescent; Adult; Aged; Alprazolam; Amitriptyline; Benzodiazepines; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Psychiatric Status Rating Scales; Random Allocation; Sleep, REM | 1985 |
Benzodiazepines as antidepressants. A triazolobenzodiazepine used to treat depression.
Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Doxepin; Humans; Psychiatric Status Rating Scales | 1982 |
Alprazolam and amitryptyline: a double blind comparison of anxiolytic and anti-depressant activity.
Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Depression; Double-Blind Method; Humans; Ireland | 1983 |
Psychobiological predictors of antidepressant drug response.
Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Dexamethasone; Double-Blind Method; Humans; Hydrocortisone; Psychiatric Status Rating Scales; Sleep, REM | 1983 |
Treatment of depressive outpatients with lorazepam, alprazolam, amytriptyline and placebo.
Topics: Adult; Aged; Alprazolam; Amitriptyline; Antidepressive Agents; Depression; Female; Humans; Lorazepam; Male; Middle Aged; Placebo Effect; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome | 1995 |
Alprazolam and amitriptyline in the treatment of moderate depression.
Topics: Adolescent; Adult; Aged; Alprazolam; Amitriptyline; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory | 1994 |
[Pharmacologic correction of psycho-emotive disorders in the rehabilitation of patients after removal of brain tumors].
Topics: Adult; Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Brain Neoplasms; Depression; Doxepin; Emotions; Female; Humans; Male; Maprotiline; Middle Aged; Moclobemide; Mood Disorders; Neurosurgical Procedures; Nialamide; Sertraline; Thiazepines; Trazodone; Treatment Outcome | 2007 |
19 other study(ies) available for alprazolam and amitriptyline
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
Polysomnography in idiopathic muscle pain syndrome (fibrositis).
Topics: Alprazolam; Amitriptyline; Clonazepam; Electroencephalography; Fatigue Syndrome, Chronic; Female; Fibromyalgia; Humans; Male; Monitoring, Physiologic; Sensory Thresholds; Sleep Wake Disorders | 1991 |
Alprazolam for psychotic depression.
Topics: Adult; Alprazolam; Amitriptyline; Depressive Disorder; Female; Humans; Male; Perphenazine; Psychological Tests; Psychotic Disorders | 1989 |
The specificity of drug classes for the anxiety and depressive disorders.
Topics: Adult; Aged; Alprazolam; Amitriptyline; Anxiety; Depressive Disorder; Female; Humans; Middle Aged; Promethazine | 1986 |
Plasma interleukin-1 beta concentrations in panic disorder.
Topics: Adult; Alprazolam; Amitriptyline; Antibodies, Monoclonal; Anxiety; Benzodiazepines; Cytokines; Female; Humans; Interleukin-1; Male; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors; Treatment Outcome | 1994 |
Successful prolonged cardiopulmonary resuscitation after a combined intoxication with a tricyclic antidepressant, a benzodiazepine and a neuroleptic.
Topics: Adult; Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Cardiopulmonary Resuscitation; Emergencies; Female; Humans; Lorazepam; Suicide, Attempted; Thiazines; Time Factors | 2000 |
Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer.
Topics: Adult; Aged; Algorithms; Alprazolam; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Central Nervous System Stimulants; Clomipramine; Depressive Disorder, Major; Disease Progression; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Middle Aged; Neoplasm Staging; Neoplasms; Prognosis; Severity of Illness Index | 2008 |
Source characterization of nervous system active pharmaceutical ingredients in healthcare facility wastewaters.
Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Health Services for the Aged; Industrial Waste; Pharmaceutical Preparations; Sewage; Water Pollutants, Chemical | 2011 |
Prolonged toxicity after amitriptyline overdose in a patient deficient in CYP2D6 activity.
Topics: Alprazolam; Amitriptyline; Antidepressive Agents, Tricyclic; Body Temperature; Brain; Coma; Cytochrome P-450 CYP2D6; Drug Overdose; Electrocardiography; Female; Gas Chromatography-Mass Spectrometry; Genotype; Half-Life; Hemodynamics; Humans; Hypnotics and Sedatives; Magnetic Resonance Imaging; Middle Aged; Respiration, Artificial; Suicide, Attempted | 2011 |
Intralipid emulsion treatment as an antidote in lipophilic drug intoxications.
Topics: Adolescent; Adult; Alprazolam; Amitriptyline; Antidotes; Blood Pressure; Dibenzothiazepines; Drug Overdose; Fat Emulsions, Intravenous; Female; Fluoxetine; Glasgow Coma Scale; Heart Rate; Humans; Lamotrigine; Lipid Metabolism; Male; Metoprolol; Middle Aged; Nifedipine; Quetiapine Fumarate; Triazines; Young Adult | 2014 |